Home All News Page 2

All News

Internet And Biotech Related News

Our 10 Top Turnaround Situations Under $5.00.

Can These Stocks Double in Value, and Still be 70% off Their Recent High? Read More...

Tsunami of Business Headed Pressure Bio’s (PBIO) Way?

We think there is a potential Tsunami of business headed towards Pressure Bio over then next 3-5 years. And well beyond....

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies in the Psychedelic...

Initiating Coverage on Psycheceutical BioScience (BWVI). "Imagine Applying a Psychedelic Topically, Receiving the Benefits...

Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the World?

We Think it is! Webinar to discuss effectiveness. The Company does not make CBD...

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Cohen Psychedelic Research & Health Initiative Cohen Foundation Awards $5 Million for MDMA Therapy Approval Millions...

Scientists Pinpoint Location of Plaque Ruptures..

Scientists pinpoint location of plaque ruptures, and a protein that predicts them (FierceBio) Scientists have uncovered new details...

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase 2b ‘ASCEND-NASH’ Trial...

Completion of Enrollment Remains on Track for Q1, 2024 "While we recently had fireworks, we could be looking at...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note...

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Hepion Pharmaceuticals (HEPA) to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences

Latest article

Hapbee’s (HAPB) Revolutionary Sleep Aid Lands on the Shelves of Target.

When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential...

Adding Cybin (CYBN) to 2024 Top Psychedelic Stocks Watch List.

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.

ENDRA Life Science’s (NDRA) $1.23 Fatty Liver Detector Advances to Next Stage of Review...

Gentleman start your engines! Endra (NDRA) recently announced it has advanced to 'substantive review*' with the U.S. Food...